Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP819215.RAKKG8HrNFQaHXG4wPQMN3Oe9IYC-EtlF-vCOF0_opQxk130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP819215.RAKKG8HrNFQaHXG4wPQMN3Oe9IYC-EtlF-vCOF0_opQxk130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP819215.RAKKG8HrNFQaHXG4wPQMN3Oe9IYC-EtlF-vCOF0_opQxk130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP819215.RAKKG8HrNFQaHXG4wPQMN3Oe9IYC-EtlF-vCOF0_opQxk130_provenance.
- NP819215.RAKKG8HrNFQaHXG4wPQMN3Oe9IYC-EtlF-vCOF0_opQxk130_assertion description "[The most suitable immunohistochemical criterion to identify basal-like breast carcinomas (BLBC), a molecular subgroup of breast cancer associated with poor prognosis, is the triple negative phenotype along with CK5 and/or EGFR immunoreactivity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP819215.RAKKG8HrNFQaHXG4wPQMN3Oe9IYC-EtlF-vCOF0_opQxk130_provenance.
- NP819215.RAKKG8HrNFQaHXG4wPQMN3Oe9IYC-EtlF-vCOF0_opQxk130_assertion evidence source_evidence_literature NP819215.RAKKG8HrNFQaHXG4wPQMN3Oe9IYC-EtlF-vCOF0_opQxk130_provenance.
- NP819215.RAKKG8HrNFQaHXG4wPQMN3Oe9IYC-EtlF-vCOF0_opQxk130_assertion SIO_000772 20552547 NP819215.RAKKG8HrNFQaHXG4wPQMN3Oe9IYC-EtlF-vCOF0_opQxk130_provenance.
- NP819215.RAKKG8HrNFQaHXG4wPQMN3Oe9IYC-EtlF-vCOF0_opQxk130_assertion wasDerivedFrom befree-2016 NP819215.RAKKG8HrNFQaHXG4wPQMN3Oe9IYC-EtlF-vCOF0_opQxk130_provenance.
- NP819215.RAKKG8HrNFQaHXG4wPQMN3Oe9IYC-EtlF-vCOF0_opQxk130_assertion wasGeneratedBy ECO_0000203 NP819215.RAKKG8HrNFQaHXG4wPQMN3Oe9IYC-EtlF-vCOF0_opQxk130_provenance.
- befree-2016 importedOn "2016-02-19" NP819215.RAKKG8HrNFQaHXG4wPQMN3Oe9IYC-EtlF-vCOF0_opQxk130_provenance.